Beconase
- Generic Name: beclomethasone nasal
- Brand Name: Beconase
- Drug Class: Corticosteroids, Intranasal
Beconase (Beclomethasone Nasal) side effects drug center
- Related Drugs
- Health Resources
- Related Supplements
- Drug Comparison
- sneezing,
- runny or stuffy nose,
- dryness or irritation in your nose or throat,
- nausea,
- headache,
- lightheadedness,
- unpleasant taste or smell,
- itching or rash, or
- sores or white patches inside or around your nose
- severe or ongoing nosebleed;
- sores in the nose that won't heal;
- blurred vision, eye pain, or seeing halos around lights;
- signs of a hormonal disorder--worsening tiredness or muscle weakness, anxiety, feeling irritable, feeling light-headed, nausea, vomiting, loss of appetite, diarrhea, weight loss, or weight gain (especially in your face or your upper back and torso); or
- signs of infection--fever, chills, sores or white patches in or around your nose, flu symptoms, redness or swelling.
- discomfort or irritation inside your nose;
- sneezing, runny or stuffy nose;
- nosebleed;
- fever, sore throat;
- headache, nausea; or
- unpleasant taste or smell.
What Is Beconase?
Beconase (beclomethasone nasal) is a steroid used to treat nasal symptoms such as congestion, sneezing, and runny nose caused by seasonal or year-round allergies. Beconase is also used to keep nasal polyps from coming back after surgery to remove them. The brand name Beconase is discontinued, but generic versions may be available.
What Are Side Effects of Beconase?
Common side effects of Beconase (beclomethasone nasal) include:
Dosage for Beconase
The usual dosage of Beconase for adults and children 12 and older is one inhalation (42 mcg) in each nostril two to four times a day (total dose, 168 to 336 mcg per day). Patients can often be maintained on a maximum dose of one inhalation in each nostril three times a day (252 mcg per day).
What Drugs, Substances, or Supplements Interact with Beconase?
Beconase may interact with other drugs. Tell your doctor all medications and supplements you use.
Beconase During Pregnancy and Breastfeeding
Beconase may be harmful to a fetus. Tell your doctor if you are pregnant or plan to become pregnant during treatment. It is unknown if this drug passes into breast milk or if it could harm a nursing baby. Consult your doctor before breastfeeding.
Additional Information
Our Beconase (beclomethasone nasal) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have:
Beclomethasone nasal can affect growth in children. Talk with your doctor if you think your child is not growing at a normal rate while using this medicine.
Common side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Read the entire detailed patient monograph for Beconase (Beclomethasone Nasal)
SIDE EFFECTS
Nasal Inhaler
In general, side effects in clinical studies have been primarily associated with the nasal mucous membranes.
Adverse reactions reported in controlled clinical trials and long-term open studies in patients treated with beclomethasone dipropionate nasal inhaler are described below.
Sensations of irritation and burning in the nose (11 per 100 patients) following the use of beclomethasone dipropionate nasal inhaler have been reported. Also, occasional sneezing attacks (10 per 100 adult patients) have occurred immediately following the use of the intranasal inhaler. This symptom may be more common in children. Rhinorrhea may occur occasionally (1 per 100 patients).
Localized infections of the nose and pharynx with Candida albicans have occurred rarely (see PRECAUTIONS).
Transient episodes of epistaxis have been reported in 2 per 100 patients.
Rare cases of ulceration of the nasal mucosa and instances of nasal septum perforation have been spontaneously reported (see PRECAUTIONS).
Reports of headache, light-headedness, dryness and irritation of the nose and throat, and unpleasant taste and smell have been received. There are rare reports of loss of taste and smell.
Rare instances of wheezing, cataracts, glaucoma and increased intraocular pressure have been reported following the intranasal application of aerosolized corticosteroids (see PRECAUTIONS).
Rare cases of immediate and delayed hypersensitivity reactions, including urticaria, angioedema, rash, and bronchospasm, have been reported following the oral and intranasal inhalation of beclomethasone.
Systemic corticosteroid side effects were not reported during the controlled clinical trials. If recommended doses are exceeded, however, or if individuals are particularly sensitive, symptoms of hypercorticism (i.e., Cushing's syndrome, could occur).
Nasal Spray
In general, side effects in clinical studies have been primarily associated with irritation of the nasal mucous membranes. Rare cases of immediate and delayed hypersensitivity reactions, including urticaria, angioedema, rash, and bronchospasm, have been reported following the oral and intranasal inhalation of beclomethasone dipropionate.
Adverse reactions reported in controlled clinical trials and open studies in patients treated with beclomethasone dipropionate nasal spray are described below.
Mild nasopharyngeal irritation following the use of beclomethasone aqueous nasal spray has been reported in up to 24% of patients treated, including occasional sneezing attacks (about 4%) occurring immediately following use of the spray. In patients experiencing these symptoms, none had to discontinue treatment. The incidence of transient irritation and sneezing was approximately the same in the group of patients who received placebo in these studies, implying that these complaints may be related to vehicle components of the formulation.
Fewer than 5 per 100 patients reported headache, nausea, or lightheadedness following the use of beclomethasone dipropionate nasal spray. Fewer than 3 per 100 patients reported nasal stuffiness, nosebleeds, rhinorrhea, or tearing eyes.
Rare cases of ulceration of the nasal mucosa and instances of nasal septum perforation have been spontaneously reported (see PRECAUTIONS).
Reports of dryness and irritation of the nose and throat, and unpleasant taste and smell have been received. There are rare reports of loss of taste and smell.
Rare instances of wheezing, cataracts, glaucoma, and increased intraocular pressure have been reported following the use of intranasal beclomethasone (see PRECAUTIONS).
Read the entire FDA prescribing information for Beconase (Beclomethasone Nasal)
© Beconase Patient Information is supplied by Cerner Multum, Inc. and Beconase Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.
